{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:34:11Z","timestamp":1787009651636,"version":"build-2736575974"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antipsychotics are the treatment of choice for schizophrenia, but they often induce akathisia. However, comparative efficacy of treatment strategies for akathisia remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We performed a systematic review and network meta-analyses (PROSPERO CRD42023450720). We searched multiple databases on July 24, 2023. We included randomized clinical trials comparing 1 or more treatment strategies for antipsychotic-induced akathisia against each other or control conditions. We included adults with schizophrenia or other psychiatric disorders treated with antipsychotics. The primary outcome was akathisia severity at posttreatment. Secondary outcomes included akathisia response, all-cause dropout, psychotic symptoms, and long-term akathisia severity. We synthesized data in random effects frequentist network meta-analyses and assessed confidence in the evidence using CINeMA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 19 trials with 661 randomized participants (mean age 35.9 [standard deviation 12.0]; 36.7% [195 of 532] women). No trials examined dose reduction or switching of antipsychotics. Findings suggested 5-HT2A antagonists (k\u2005=\u20056, n\u2005=\u2005108; standardized mean difference [SMD] \u22121.07 [95% confidence interval, \u22121.42; \u22120.71]) and beta-blockers (k\u2005=\u20058, n\u2005=\u2005105; SMD \u22120.46 [\u22120.85; \u22120.07]) may improve akathisia severity, but confidence in the evidence was deemed low. We also found that benzodiazepines (k\u2005=\u20052, n\u2005=\u200513; SMD \u22121.62 [\u22122.64; \u22120.59]) and vitamin B6 (k\u2005=\u20053, n\u2005=\u200567; SMD \u22120.99 [\u22121.49; \u22120.50]) might also be beneficial, but confidence in the evidence was very low. Analyses of secondary outcomes did not provide additional insights.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that 5-HT2A antagonists, beta-blockers, and with a lesser certainty, benzodiazepines, and vitamin B6 might improve akathisia. Given the low to very low confidence in the evidence of add-on agents and the absence of evidence of their long-term efficacy, careful consideration of side effects is warranted. These recommendations are extremely preliminary and further trials are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/schbul\/sbae098","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T02:14:25Z","timestamp":1716516865000},"source":"Crossref","is-referenced-by-count":8,"title":["Comparative Efficacy and Acceptability of Treatment Strategies for Antipsychotic-Induced Akathisia: A Systematic Review and Network Meta-analysis"],"prefix":"10.1093","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1317-0220","authenticated-orcid":false,"given":"Yuki","family":"Furukawa","sequence":"first","affiliation":[{"name":"Department of Neuropsychiatry, University of Tokyo Hospital , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Imai","sequence":"additional","affiliation":[{"name":"Pharmaceutical Department, University of Tokyo Hospital , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, University of Tokyo Hospital , Tokyo ,","place":["Japan"]},{"name":"Department of Psychiatry, Tokyo Musashino Hospital , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0955-7572","authenticated-orcid":false,"given":"Orestis","family":"Efthimiou","sequence":"additional","affiliation":[{"name":"Institute of Primary Health Care (BIHAM), Faculty of Medicine,\u00a0University of Bern , Bern ,","place":["Switzerland"]},{"name":"Institute of Social and Preventive Medicine (ISPM), Faculty of Medicine,\u00a0University of Bern , Bern ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4934-4352","authenticated-orcid":false,"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, School of Medicine and Health, Technical University of Munich , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"2026032106211495900_CIT0001","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/JCP.0b013e3182677958","article-title":"Akathisia and suicidal ideation in first-episode schizophrenia","volume":"32","author":"Seem\u00fcller","year":"2012","journal-title":"J Clin Psychopharmacol."},{"key":"2026032106211495900_CIT0002","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.schres.2015.10.040","article-title":"Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset","volume":"169","author":"Berna","year":"2015","journal-title":"Schizophr Res."},{"key":"2026032106211495900_CIT0003","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1017\/neu.2022.9","article-title":"Akathisia and atypical antipsychotics: relation to suicidality, agitation and depression in a clinical trial","volume":"34","author":"Bjarke","year":"2022","journal-title":"Acta Neuropsychiatr."},{"key":"2026032106211495900_CIT0004","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1176\/appi.ajp.2020.177901","article-title":"The American psychiatric association practice guideline for the treatment of patients with schizophrenia","volume":"177","author":"Keepers","year":"2020","journal-title":"Am J Psychiatry."},{"key":"2026032106211495900_CIT0005","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/npr2.12193","article-title":"Japanese society of neuropsychopharmacology: \u201cguideline for pharmacological therapy of schizophrenia.\u201d","volume":"41","author":"Neuropsychopharmacology","year":"2021","journal-title":"Neuropsychopharmacol Rep."},{"key":"2026032106211495900_CIT0006","first-page":"339","article-title":"Fluoxetine-induced akathisia: clinical and theoretical implications","volume":"50","author":"Lipinski","year":"1989","journal-title":"J Clin Psychiatry."},{"key":"2026032106211495900_CIT0007","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/JCP.0000000000000412","article-title":"Treatment of antipsychotic-related akathisia revisited","volume":"35","author":"Poyurovsky","year":"2015","journal-title":"J Clin Psychopharmacol."},{"key":"2026032106211495900_CIT0008","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.euroneuro.2009.02.006","article-title":"Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study","volume":"19","author":"Avital","year":"2009","journal-title":"Eur Neuropsychopharmacol."},{"key":"2026032106211495900_CIT0009","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004714-198912000-00003","article-title":"Successful clonazepam treatment of neuroleptic-induced akathisia in older adolescents and young adults","volume":"9","author":"Kutcher","year":"1989","journal-title":"J Clin Psychopharmacol."},{"key":"2026032106211495900_CIT0010","first-page":"130","article-title":"Effect of vitamin B6 versus propranolol on antipsychotic-induced akathisia: a pilot comparative double-blind study","volume":"17","author":"Shams-Alizadeh","year":"2018","journal-title":"Iran J Pharm Res."},{"key":"2026032106211495900_CIT0011","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/0706743718760288","article-title":"The assessment and treatment of antipsychotic-induced akathisia","volume":"63","author":"Pringsheim","year":"2018","journal-title":"Can J Psychiatry."},{"key":"2026032106211495900_CIT0012","doi-asserted-by":"crossref","first-page":"e241527","DOI":"10.1001\/jamanetworkopen.2024.1527","article-title":"Drug efficacy in the treatment of antipsychotic-induced akathisia","volume":"7","author":"Gerolymos","year":"2024","journal-title":"JAMA Netw Open."},{"key":"2026032106211495900_CIT0013","doi-asserted-by":"crossref","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med."},{"key":"2026032106211495900_CIT0014","doi-asserted-by":"crossref","first-page":"e074495","DOI":"10.1136\/bmj-2022-074495","article-title":"A guide and pragmatic considerations for applying GRADE to network meta-analysis","volume":"381","author":"Izcovich","year":"2023","journal-title":"BMJ."},{"key":"2026032106211495900_CIT0015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med."},{"key":"2026032106211495900_CIT0016","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet."},{"key":"2026032106211495900_CIT0017","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ."},{"key":"2026032106211495900_CIT0018","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry."},{"key":"2026032106211495900_CIT0019","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jclinepi.2020.08.019","article-title":"Questionable utility of the relative risk in clinical research: a call for change to practice","volume":"142","author":"Doi","year":"2020","journal-title":"J Clin Epidemiol."},{"key":"2026032106211495900_CIT0020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jrsm.1195","article-title":"GetReal in network meta-analysis: a review of the methodology","volume":"7","author":"Efthimiou","year":"2016","journal-title":"Res Synth Methods."},{"key":"2026032106211495900_CIT0021","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res Synth Methods."},{"key":"2026032106211495900_CIT0022","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med."},{"key":"2026032106211495900_CIT0023","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol."},{"key":"2026032106211495900_CIT0024","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jrsm.1428","article-title":"The Kilim plot: a tool for visualizing network meta-analysis results for multiple outcomes","volume":"12","author":"Seo","year":"2021","journal-title":"Res Synth Methods."},{"key":"2026032106211495900_CIT0025","doi-asserted-by":"crossref","first-page":"e056400","DOI":"10.1136\/bmjopen-2021-056400","article-title":"Development and design validation of a novel network meta-analysis presentation tool for multiple outcomes: a qualitative descriptive study","volume":"12","author":"Phillips","year":"2022","journal-title":"BMJ Open."},{"key":"2026032106211495900_CIT0026","doi-asserted-by":"crossref","first-page":"e300978","DOI":"10.1136\/bmjment-2023-300978","article-title":"Understanding effect size: an international online survey among psychiatrists, psychologists, physicians from other medical specialities, dentists and other health professionals","volume":"27","author":"Heimke","year":"2024","journal-title":"BMJ Ment Health."},{"key":"2026032106211495900_CIT0027","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2020"},{"key":"2026032106211495900_CIT0028","author":"R\u00fccker","year":"2020"},{"key":"2026032106211495900_CIT0029","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health."},{"key":"2026032106211495900_CIT0030","doi-asserted-by":"crossref","DOI":"10.1016\/0924-977X(95)90714-O","article-title":"A beta-adrenoceptor antagonist, carteolol, in the treatment of neuroleptic-induced akathisia","author":"Aoba","year":"1995"},{"key":"2026032106211495900_CIT0031","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1176\/ajp.149.5.647","article-title":"Randomized, double-blind, crossover, placebo-controlled comparison of propranolol and betaxolol in the treatment of neuroleptic-induced akathisia","volume":"149","author":"Dumon","year":"1992","journal-title":"Am J Psychiatry."},{"key":"2026032106211495900_CIT0032","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/jcp.0b013e3180582439","article-title":"The effectiveness of intramuscular biperiden in acute akathisia","volume":"27","author":"Baskak","year":"2007","journal-title":"J Clin Psychopharmacol."},{"key":"2026032106211495900_CIT0033","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00004714-200112000-00013","article-title":"Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study","volume":"21","author":"Fischel","year":"2001","journal-title":"J Clin Psychopharmacol."},{"key":"2026032106211495900_CIT0034","first-page":"244","article-title":"Propranolol as a primary treatment of neuroleptic-induced akathisia","volume":"10","author":"Irwin","year":"1988","journal-title":"Hillside J Clin Psychiatry."},{"key":"2026032106211495900_CIT0035","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0006-3223(88)90260-0","article-title":"Propranolol in the treatment of neuroleptic-induced akathisia (NIA) in schizophrenics: a double-blind, placebo-controlled study","volume":"24","author":"Kramer","year":"1988","journal-title":"Biol Psychiatry."},{"key":"2026032106211495900_CIT0036","first-page":"107","article-title":"Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study","volume":"11","author":"Kramer","year":"1989","journal-title":"Hillside J Clin Psychiatry."},{"key":"2026032106211495900_CIT0037","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.4088\/JCP.v65n1118","article-title":"Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study","volume":"65","author":"Lerner","year":"2004","journal-title":"J Clin Psychiatry."},{"key":"2026032106211495900_CIT0038","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00002826-200603000-00002","article-title":"Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study","volume":"29","author":"Miodownik","year":"2006","journal-title":"Clin Neuropharmacol."},{"key":"2026032106211495900_CIT0039","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1192\/bjp.174.3.238","article-title":"Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin","volume":"174","author":"Poyurovsky","year":"1999","journal-title":"Br J Psychiatry."},{"key":"2026032106211495900_CIT0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.jcp.0000084027.22282.16","article-title":"Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study","volume":"23","author":"Poyurovsky","year":"2003","journal-title":"J Clin Psychopharmacol."},{"key":"2026032106211495900_CIT0041","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.biopsych.2005.12.007","article-title":"Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial","volume":"59","author":"Poyurovsky","year":"2006","journal-title":"Biol Psychiatry."},{"key":"2026032106211495900_CIT0042","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00002826-199406000-00003","article-title":"A Double-blind comparison of clonazepam and placebo in the treatment of neuroleptic-induced akathisia","volume":"17","author":"Pujalte","year":"1994","journal-title":"Clin Neuropharmacol."},{"key":"2026032106211495900_CIT0043","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/JCP.0000000000001286","article-title":"Trazodone as an alternative treatment for neuroleptic-associated akathisia: a placebo-controlled, double-blind, clinical trial","volume":"40","author":"Shams-Alizadeh","year":"2020","journal-title":"J Clin Psychopharmacol."},{"key":"2026032106211495900_CIT0044","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/WNF.0b013e3181ee7f63","article-title":"Trazodone for the treatment of neuroleptic-induced acute akathisia","volume":"33","author":"Stryjer","year":"2010","journal-title":"Clin Neuropharmacol."},{"key":"2026032106211495900_CIT0045","first-page":"255","article-title":"A placebo-controlled trial of nadolol in the treatment of neuroleptic-induced akathisia","volume":"52","author":"Wells","year":"1991","journal-title":"J Clin Psychiatry."},{"key":"2026032106211495900_CIT0046","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-0447.1983.tb00339.x","article-title":"Sodium vaiproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia","volume":"67","author":"Friis","year":"1983","journal-title":"Acta Psychiatr Scand."},{"key":"2026032106211495900_CIT0047","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euroneuro.2023.03.015","article-title":"Antipsychotic-induced akathisia in adults with acute schizophrenia: a systematic review and dose-response meta-analysis","volume":"72","author":"Wu","year":"2023","journal-title":"Eur Neuropsychopharmacol."},{"key":"2026032106211495900_CIT0048","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12991-023-00465-y","article-title":"Role of trazodone in treatment of major depressive disorder: an update","volume":"22","author":"Fagiolini","year":"2023","journal-title":"Ann Gen Psychiatry."},{"key":"2026032106211495900_CIT0049","first-page":"CD006528","article-title":"Mirtazapine versus other antidepressive agents for depression","volume":"12","author":"Watanabe","year":"2011","journal-title":"Cochrane Database Syst Rev."},{"key":"2026032106211495900_CIT0050","first-page":"CD002003","article-title":"Beta-blockers for hypertension","volume":"2017","author":"Wiysonge","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"2026032106211495900_CIT0051","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(22)00878-9","article-title":"Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis","volume":"400","author":"De Crescenzo","year":"2022","journal-title":"Lancet."},{"key":"2026032106211495900_CIT0052","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJMra1611832","article-title":"Treatment of benzodiazepine dependence","volume":"376","author":"Michael","year":"2017","journal-title":"N Engl J Med."},{"key":"2026032106211495900_CIT0053","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch Intern Med."},{"key":"2026032106211495900_CIT0054","doi-asserted-by":"crossref","first-page":"111738","DOI":"10.1016\/j.nut.2022.111738","article-title":"Problematic rise of vitamin B6 supplementation overuse and potential risk to bariatric surgery patients","volume":"102","author":"Bossard","year":"2022","journal-title":"Nutrition."},{"key":"2026032106211495900_CIT0055","doi-asserted-by":"crossref","first-page":"f2304","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ."}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/2\/sbae098\/60876241\/sbae098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/2\/sbae098\/60876241\/sbae098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T10:21:31Z","timestamp":1774088491000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/doi\/10.1093\/schbul\/sbae098\/7692844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6,13]]},"published-print":{"date-parts":[[2026,3,7]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbae098","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.06.24303827","asserted-by":"object"}]},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2024,6,13]]},"article-number":"sbae098"}}